Profil
Kenji Tsuge has founded Synplogen Co., Ltd.
in 2017, where he currently holds the title of Director.
He received his undergraduate degree from Saitama University in 1993 and his doctorate degree from Tokyo Institute of Technology in 1998.
Aktive Positionen von Kenji Tsuge
| Unternehmen | Position | Beginn |
|---|---|---|
Synplogen Co., Ltd.
 Synplogen Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Synplogen Co., Ltd. is a synthetic biology startup that provides DNA synthesis and DNA library construction services using their proprietary DNA synthesis technologies OGAB™ and Combinatorial-OGAB. The company was founded in 2017 by Akihiko Kondo and Kenji Tsuge and is based in Kobe, Japan. The Japanese company also offers design, development, and analysis services for gene therapy products such as viral vectors through their Gene Therapy Biofoundry™ service. | Gründer | 21.02.2017 |
Ausbildung von Kenji Tsuge
| Saitama University | Undergraduate Degree |
| Tokyo Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Synplogen Co., Ltd.
Synplogen Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Synplogen Co., Ltd. is a synthetic biology startup that provides DNA synthesis and DNA library construction services using their proprietary DNA synthesis technologies OGAB™ and Combinatorial-OGAB. The company was founded in 2017 by Akihiko Kondo and Kenji Tsuge and is based in Kobe, Japan. The Japanese company also offers design, development, and analysis services for gene therapy products such as viral vectors through their Gene Therapy Biofoundry™ service. | Commercial Services |
